Position in NVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$237,587
+$16,100 QoQ
Shares Held
1,516
+4.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,240
of 1,603 holders
Holding Since
Sep 2021
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CPC Advisors, LLC holds $7,718,083 across 7 Drug Manufacturers - General names. NVS ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,029 | $4,578,825 | |
| 2 | LLY |
ELI LILLY & Co
|
1,261 | $1,512,481 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,842 | $493,697 | |
| 4 | ABBV |
AbbVie Inc.
|
1,704 | $428,794 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,937 | $244,720 | |
| 6 | NVS |
Novartis AG
This page
|
1,516 | $237,587 | |
| 7 | AMGN |
Amgen Inc
|
613 | $221,979 |
All Filings in NVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $237,587 | 1,516 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $221,487 | 1,450 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $200,600 | 1,455 | Shares | Sole | 2026-01-28 | |
| 2021-09-30 | $42,443 | 519 | Shares | Sole | 2021-11-17 | |
| No filing history on record for this holder in this stock. | ||||||